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Extensive loss of adipose tissue is a hallmark of cancer cachexia but the cellular and molecular basis remains unclear. This study has
examined morphologic and molecular characteristics of white adipose tissue in mice bearing a cachexia-inducing tumour, MAC16.
Adipose tissue from tumour-bearing mice contained shrunken adipocytes that were heterogeneous in size. Increased fibrosis was
evident by strong collagen-fibril staining in the tissue matrix. Ultrastructure of ‘slimmed’ adipocytes revealed severe delipidation and
modifications in cell membrane conformation. There were major reductions in mRNA levels of adipogenic transcription factors
including CCAAT/enhancer binding protein alpha (C/EBPa), CCAAT/enhancer binding protein beta, peroxisome proliferator-
activated receptor gamma, and sterol regulatory element binding protein-1c (SREBP-1c) in adipose tissue, which was accompanied by
reduced protein content of C/EBPa and SREBP-1. mRNA levels of SREBP-1c targets, fatty acid synthase, acetyl CoA carboxylase,
stearoyl CoA desaturase 1 and glycerol-3-phosphate acyl transferase, also fell as did glucose transporter-4 and leptin. In contrast,
mRNA levels of peroxisome proliferators-activated receptor gamma coactivator-1alpha and uncoupling protein-2 were increased in
white fat of tumour-bearing mice. These results suggest that the tumour-induced impairment in the formation and lipid storing
capacity of adipose tissue occurs in mice with cancer cachexia.
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Cancer cachexia is a metabolic disorder characterised by
progressive loss of body weight with depletion of skeletal muscle
and adipose tissue (Argiles et al, 2003). Cachexia and its
consequences are detrimental and considered to be the direct
cause of B20% of cancer deaths (Tisdale, 2002). Adipose atrophy
is a hallmark of cancer cachexia, up to a 85% decrease in body fat
being reported in lung cancer patients, which may lead to
hyperlipidaemia and insulin resistance as well as complicate
antitumour therapies. Loss of fat stores cannot be explained by
reduced appetite alone as it often precedes the onset of anorexia
and is severe in animal model of cachexia than that of food
restriction (Bing et al, 2000). Evidence has accumulated that the
disease progress triggers catabolic responses that override
anabolism at the peripheral tissues.
The importance of white adipose tissue in the control of
adiposity has been recognised with the discovery of adipocyte-
secreted adipokines which regulate body weight (Trayhurn & Bing,
2006), and by the studies indicating that adipocyte metabolism
potently affects body fat accumulation (Orci et al, 2004). Although
the defects in adipocyte development and metabolism are
implicated in the pathogenesis of HIV-related lipodystrophy
(Bastard et al, 2002), little is known the mechanism underlying
malignancy-related lipoatrophy. Lipolysis appears to be increased
in cancer cachexia since in white fat lipoprotein lipase activity is
decreased in tumour-bearing mice (Thompson et al, 1981) while
hormone sensitive lipase mRNA is elevated in cancer patients with
cachexia (Thompson et al, 1993). In addition, hyperlipidaemia is
often present in cachectic cancer patients (Rofe et al, 1994) and in
tumour-bearing rats (Lopez-Soriano et al, 1997a). These changes
are thought to be induced by cachexia mediators such as the
inflammatory cytokine TNFa and tumour-derived lipid-mobilising
factors (Tisdale, 2002).
Adipose tissue mass is also influenced by adipogenesis that
involves the recruitment of new adipocytes (preadipocyte differ-
entiation) and adipocyte maturation. Adipocyte differentiation is a
highly controlled process through sequential activation of
transcription factors that regulate the expression of adipocyte-
specific markers (Mandrup & Lane, 1997). The early event involves
increases in C/EBPb and d in a transient manner, which enables
the distinction between a preadipocyte and nonadipogenic
precursor cell. C/EBPb and d activate the expression of peroxisome
proliferator-activated receptor gamma (PPARg), which in turn
stimulates C/EBPa expression, and C/EBPa synergises with PPARg
in controlling terminal differentiation (Rosen, 2005). Differentia-
tion is enhanced by sterol regulatory element binding protein-1c
(SREBP-1c), which activates PPARg transcription (Fajas et al, Revised 16 August 2006; accepted 22 August 2006
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s1999). Adipocyte maturation is accompanied by intracellular
accumulation of lipid, and SREBP-1c activates the lipogenic
pathway by stimulating the expression of genes encoding lipogenic
enzymes, such as acetyl-CoA carboxylase (ACC), fatty acid
synthase (FAS), stearoyl-CoA desaturase-1 (SCD-1) and glycerol-
3-phosphate acyltransferase (GPAT) (Shimano et al, 1999).
Glucose, which serves as a substrate for lipid synthesis, is
transported into the adipocyte via the insulin-responsive glucose
transporter-4 (Glut-4). However, it remains unknown whether the
tumour-burden affects adipocyte development in adipose tissue.
Peroxisome proliferators-activated receptor gamma coactivator-
1a (PGC-1a) plays a central role in the coordination of adaptive
thermogenesis through increased mitochondrial biogenesis and
oxidative metabolisms in brown adipose tissue (BAT) and skeletal
muscle (Puigserver et al, 1998). PGC-1a is also expressed in white
fat with low baseline levels in both rodents and humans (Kakuma
et al, 2000; Semple et al, 2004). Overexpression of PGC-1a in
human adipocytes enhances mitochondrial activities prompting
white adipocytes away from fat storage towards lipid utilisation
(Tiraby et al, 2003). Conversely, diminished PGC-1a mRNA in
white fat has been reported in morbidly obese subjects (Semple
et al, 2004). A question that has not yet been explored is whether
PGC-1a expression in white fat is altered in cancer cachexia.
In this study, we have examined the morphologic characteristics
of white adipose tissue from mice bearing the MAC16 colon
adeocarcinoma, a cachexia model which induces profound loss of
lean mass and fat mass without severe anorexia (Bibby et al, 1987).
We have further explored the molecular basis by which tumour-
burden could alter adipose tissue mass and function, by assessing
the expression of genes that control adipocyte differentiation,
lipogenesis and lipid utilisation in white fat of tumour-bearing
mice as compared with both freely fed and pair-fed nontumour-
bearing controls. We show that the tumour-burden induces
profound alterations of adipose tissue plasticity and ultrastructural
modifications of adipocytes. Our data also show the major
reductions in the transcription of adipogenic and lipogenic factors,
suggesting that impairment in the formation and lipid-storing
function of adipose tissue occurs in cancer cachexia.
MATERIALS AND METHODS
Animals
NMRI mice (20–22g) from an inbred colony at Aston University
(Birmingham, UK) were kept at an ambient temperature of
22721C under a 12:12h light–dark cycle (lights on at 0700 hours)
and fed a standard diet (SDS economy breeder; Lillico, UK) with
water ad libitum. Fragments of the MAC16 tumour were implanted
subcutaneously into the flank of mice using a trocar. The weight-
matched mice underwent sham operation and served as freely fed
or pair-fed controls, which were pair-fed to match the food intake
of tumour-bearing mice. Food intake and body weight were
recorded. At 18 days after tumour inoculation, mice were killed by
cervical dislocation. Epididymal white fat and interscapular BAT
were removed and were fixed for microscopy or snap-frozen in
liquid N2 and then stored at  801C until analysis. Animal studies
were conducted according to the UKCCCR Guidelines for the care
and use of laboratory animals.
Light microscopy
Epididymal fat pads from tumour-bearing and control mice were
fixed in 10% neutral formalin for 24h, dehydrated in absolute
ethanol, cleared in xylene and then embedded in paraffin. The
paraffin was cut into 5-mm sections that were stained with Harris
haematoxylin, counterstained with eosin, and then evaluated by
light microscopy. To detect collagen fibre content, sections were
stained with Sirius Red. For quantification of adipocyte size,
sections were analysed by using an Optiphot-2 microscope (Nikon,
Japan) equipped with a digital camera. The cell perimeter and
sectional area were measured in 100 adipocytes per section (three
sections for one mouse and five animals per group), and data
analysis performed using the MCID Basic software (Imaging
Reseaech Inc., Ontario, Canada) for digital image processing.
Electron microscopy
Epididymal fat pads were cut into slices while fixed in 2.5%
glutaraldehyde and 4% paraformaldehyde in 0.1 M cacodylate
buffer (pH 7.4). Specimens were postfixed with 1% osmium
tetroxide, dehydrated through an ascending series of ethanol, and
embedded in Taab epoxy resin. Semithin (2mm) and ultrathin
sections (60nm) were cut on a Reichert–Jung ultracut microtome.
The semithin sections were stained with 1% toluidine blue and
examined with a light microscope. The adjacent thin sections were
double-contrasted with uranylacetate followed by lead citrate, and
viewed and photographed with a Hitachi H600 transmission
electron microscope (Hitachi Ltd, Tokyo, Japan).
Real-time PCR
Total RNA was extracted from tissues using Trizol (Invitrogen,
Carlsbad, CA, USA) and the RNA concentration determined from
the absorbance at 260nm. First strand DNA was reverse
transcribed from 1mg of total RNA by using a Reverse-iTt first
strand synthesis kit (ABgene, Epson, UK) in a final volume of 20ml.
The real-time PCR amplification was performed in a final volume
of 25ml, containing 1ml cDNA (equivalent to 50ng of RNA),
forward and reverse primers, TaqMan
sprobe FAM-TAMRA
(Table 1), and a master mix made from qPCR core kit (Eurogentec,
Southampton, UK). PCR amplifications and efficiency were
optimised according to the manufacturer’s protocol and per-
formed by using the ABI PRISM 7700 Sequence Detector (Applied
Biosystems, Foster City, CA, USA) described previously (Bing et al,
2004). All samples were normalised to the b-actin values and the
results were expressed as fold changes of Ct value relative to
controls using the 2 DDCt formula (Livak & Schmittgen, 2001). b-
Actin was used as a reference gene since we have experimentally
determined, that there were no statistically significant differences
of its Ct values between control and tumour-bearing or pair-feding
groups (both P40.05, three experiments).
Western blotting
Proteins were isolated from epididymal fat. Samples containing
20mg of protein were separated by electrophoresis on a 12% SDS–
polyacrylamide gel. Proteins were then transferred to nitro-
cellulose membranes (Amersham Inc., UK). Immunoblotting was
performed using polyclonal antibodies against C/EBPa (14AA) and
SREBP-1 (K-10) (Santa Cruz, CA, USA) at a 1:500 dilution. Blots
were then incubated with sheep anti-rabbit IgG conjugated to
horseradish peroxidase (Serotec, Oxford, UK) at 1:2000 for 1h at
room temperature, and were detected by enhanced chemilumines-
cence (ECL; Amersham, Buckinghamshire, UK). For the control of
protein equal loading, blots were stripped and then incubated with
a mouse monoclonal anti-b-tubulin antibody (Sigma, Poole,
Dorset, UK) at 1:10000, and subsequently incubated with a rabbit
anti-mouse IgG (Santa Cruz) at 1:1000.
Statistical analysis
Data are expressed as mean values 7s.e.m. Differences between
groups were analysed by analysis of variance (ANOVA) coupled
with Bonferroni’s t-tests using ARCUS statistical software (Medical
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sComputing, Liverpool, UK). Differences were considered as
statistically significant when Po0.05.
RESULTS
Tumour-bearing mice had considerably reduced body weight
compared with freely fed and pair-fed controls (both Po0.01), and
their final body weight was significantly lower than initial weight
(Figure 1A). Pair-fed animals did not lose weight although their
body weight was lower relative to controls (Po0.01) (Figure 1A).
Fat mass was also markedly reduced in tumour-bearing mice while
it was moderately decreased in pair-fed animals when compared
with controls ( 67% and  21%, both Po0.01) (Figure 1B). Total
food intake was mildly reduced ( 14%) in tumour-bearing mice
relative to controls (Po0.01) (Figure 1C). These results confirm
that the tumour-burden induces much greater reductions in body
weight and fat mass than that of food restriction, demonstrating a
strong cachectic effect of the MAC16 tumour on adiposity.
Examination under light microscopy has shown substantial
morphological alterations of adipose tissue in tumour-bearing
mice compared with freely fed and pair-fed controls. This was
characterised by the tissue containing shrunken adipocytes of
various sizes with a dilated interstitial space (Figure 2Aa–c). In
lipoatrophic areas most adipocytes displayed irregular cell outlines
(Figure 2Ac). There was no apparent infiltration of monocytes
observed in adipose tissue (Figure 2Ac). Further morphometric
analysis has revealed that the adipocyte size, determined as cell
perimeter (Figure 2B) and sectional area (Figure 2C), was
dramatically reduced in tumour-bearing mice, compared with
freely fed and pair-fed controls (all Po0.01). To examine the
nature of extracellular matrix, sections of white fat were stained
with Sirius Red. There was a strong Sirius Red staining in the
stroma of white fat from tumour-bearing mice, indicating a
remarkable increase in collagen-fibril content in adipose tissue.
However, fat cells retained a spherical appearance with only
slightly increased collagen-fibril staining in the tissue matrix in
pair-fed mice (Figure 2Da–c).
To further analyse the ultrastructural features of ‘slimmed’
adipocytes, transmission electron microscopy was performed
using sections of epididymal white fat from tumour-bearing
mice and freely fed controls. In agreement with what was observed
by light microscopy, adipocytes from control mice were char-
acterised by the cell containing a large lipid droplet with a thin
peripheral rim of cytoplasm and the peripherally located nucleus
(Figure 3A). In contrast, adipocytes from tumour-bearing mice
were much smaller with dilated interadipocyte space, which was
occupied by capillary vessels, while the nucleus was no longer
being pressed by the large lipid droplet (Figure 3B). The peripheral
rim of cytoplasm of the ‘slimmed’ adipocyte became thickened,
containing numerous lipid droplets that were surrounded by
mitochondria (Figure 3C). Furthermore, the mitochondria differed
from typical white adipocyte mitochondria (D), were electron
dense (Figure 3E) with increased cristae (Figure 3F). In addition,
adipocytes exhibited irregular cytoplasmic projections and the cell
surface was rich in small vacuoles (Figure 3E–F). These results
illustrate an adipocyte remodelling in mice bearing the MAC16
tumour.
Table 1 Sequences of primer/probe sets used in real-time RT–PCR (TaqMan) analyses (50-30)
Accession no. Forward/reverse primers Probe
C/EBPa NM_007678 AGAGCCGAGATAAAGCCAAACA
CGGTCATTGTCACTGGTCAACT
AACGTGGAGACGCAACAGAAGGTGCT
C/EBPb NM_009883 ACAAGCTGAGCGACGAGTACAA
TGTGCTGCGTCTCCAGGTT
CGCGAGCGCAACAACATCGC
PPARg AY243585 AGTGGAGACCGCCCAGG
GCAGCAGGTTGTCTTGGATGT
TTGCTGAACGTGAAGCCCATCGAG
Glut-4 AB008453 CATCCCACAAGGCACCCTC
CATGCCACCCACAGAGAAGA
CTACGCTCTGGGCTCTCTCCGTGG
Leptin NM_008493 CATCTGCTGGCCTTCTCCAA
ATCCAGGCTCTCTGGCTTCTG
AGCTGCTCCCTGCCTCAGACCAGTG
SREBP-1c NM_011480 GGCACTAAGTGCCCTCAACCT
GCCACATAGATCTCTGCCAGTGT
TGCGCAGGAGATGCTATCTCCA
ACC NM_133366 CCCAGCAGAATAAAGCTACTTTGG
TCCTTTTGTGCAACTAGGAACGT
TGAGCATGGCATCCGGCGACT
FAS BC046513 CCTGGATAGCATTCCGAACCT
AGCACATCTCGAAGGCTACACA
CCTGAGGGACCCTACCGCATAGC
SCD-1 AF509567 TCACGACCCCACCTATCAGG
TTCCTCCAGACGTACTCCAGC
TGAGGAGGGACCCCCGCCC
GPAT MUSG3PAT CAACACCATCCCCGACATC
GTGACCTTCGATTATGCGATCA
TCGTCATACCCGTGGGCATCTCG
PGC-1a XM-126624 GATGGCACGCAGCCCTAT
CTCGACACGGAGAGTTAAAGGAA
CATTGTTCGATGTGTCGCCTTCTTGCT
UCP2 U69135 AAAGATACTCTCCTGAAAGCCAACCT
GGCCCCGAAGGCAGAA
ATGACAGATGACCTCCCTTGCCACTTCA
TNF-a NM_013693 CCCAGACCCTCACACTCAGATC
GCCACTCCAGCTGCTCCTC
TAGCCCACGTCGTAGCAAACCACCAAG
IL-6 NM_031168 ACAACCACGGCCTTCCCTACTT
CACGATTTCCCAGAGAACATGTG
TCACAGAGGATACCACTCCCAACAGACCT
MAC-1 X07640 GAATGGATTGTGCTATTTGTTCGG
CGGAGCCATCAATCAAGAAGAC
TCCAACCTGCTGAGGCCGCCC
F4/80 X93328 AAGACTTGATACTCCAAAGTGAGC
GAAGGAAGCATAACCAAGATCCC
CCCTGCACTGCTTGGCATTGCTGT
ZAG D21059 GAGCCTGTGGGACCTTGGA
CCTCCCTGGCCCTCTGAA
AATGGAGGACTGGGAGAAGGAAAGCCAG
b-Actin MMU89400 ACGGCCAGGTCATCACTATTG
CAAGAAGGAAGGCTGGAAAAGA
ACGAGCGGTTCCGATGCCCTG
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sTo explore the molecular mechanisms by which the tumour-
burden reduces fat mass, we examined the mRNA abundance of
several key adipogenic factors. mRNA levels of c/EBPb, PPARg,
c/EBPa and SREBP-1c fell significantly in tumour-bearing mice
and there was a striking 100-fold reduction in c/EBPa (Po0.01)
compared with freely fed controls (Figure 4A). Pair-feeding did not
affect expression of c/EBPb, PPARg and SREBP-1c while a
moderate decrease in c/EBPa mRNA (by six-fold, Po0.05) was
observed relative to controls. In addition, mRNA levels of Glut-4
were 10-fold lower (Po0.01) in tumour-bearing mice than in freely
fed controls, whereas pair-feeding had little effect on Glut-4
(Figure 4A). Leptin mRNA levels were dramatically decreased (by
33-fold, Po0.01) in tumour-bearing mice, but were only
moderately reduced (by four-fold, Po0.01) in pair-fed mice as
compared with controls (Figure 4A).
To examine whether the MAC16 tumour-burden affects the lipid
storing ability of adipose tissue through inhibiting fatty acid and
triglyceride synthesis, we compared the expression of SREBP-1c
target – genes encoding lipogenic enzymes, ACC, FAS, SCD-1 and
GPAT. As shown in Figure 4B, mRNA levels of all four enzymes
were significantly decreased by at least three-fold in tumour-
bearing mice (all Po0.01) with FAS mRNA showing a 10-fold
reduction, relative to controls. However, mRNA levels of the
lipogenic enzymes examined were unaffected in pair-fed animals
(Figure 4B).
To assess whether the expression of genes involved in regulating
lipid utilisation is altered in white fat of cachectic mice, we
measured mRNA levels of PGC-1a and UCP-2. As shown in
Figure 4C, low amounts of PGC-1a mRNA were detected in white
fat from freely fed controls as the abundance was only B5% of its
basal expression levels present in BAT. However, PGC-1a mRNA
levels were dramatically increased (by 13-fold, Po0.01) in white
fat of tumour-bearing mice, being 68% of the basal levels detected
in BAT. In contrast, PGC-1a mRNA was unaffected in pair-fed
animals. UCP-2 mRNA was elevated by over two-fold (Po0.01) in
tumour-bearing mice, but no changes were found in pair-fed
animals, relative to controls (Figure 4C).
To further examine whether the MAC16 tumour-induced
inhibition in gene transcription of adipogenic factors affects their
protein synthesis, the protein abundance of C/EBPa and SREBP-1c
in white fat was examined. The tumour-burden led to suppression
of C/EBPa protein (Figure 4D). By using an antibody that detects
both SREBP-1a and -1c, the latter being the major form present in
adipose tissue, a decrease in SREBP-1c protein content was
observed in tumour-bearing mice compared with controls
(Figure 4D).
In order to explore whether adipose tissue-derived cytokines
and lipid mobilising factor are involved in MAC16-induced
lipoatrophy, gene expression of TNFa, IL-6 and zinc-a2-glyco-
protein (ZAG) known as a lipid-mobilising factor, in white fat was
determined in tumour-bearing and freely fed animals. mRNA
levels of TNFa and IL-6 were unchanged in tumour-bearing mice
compared with controls (both P40.05) (Figure 5). As macrophage
(MAC) infiltration in adipose tissue is suggested to contribute to
increased local production of cytokines (Machado et al, 2004), we
have also determined mRNA levels of two MAC makers, MAC1 and
F4/80. Both were unaffected with the MAC16 tumour-burden
relative to controls (MAC1, 0.9970.37 vs 1.0070.30; F4/80,
0.7970.41 vs 1.0070.40; both P40.05, n¼8 per group). In
contrast, there was a 10-fold elevation in ZAG mRNA in tumour-
bearing animals (Po0.01 vs controls) (Figure 5).
DISCUSSION
The present work demonstrates profound changes at the
morphological and molecular levels in adipose tissue of mice with
cancer cachexia. These alterations differ greatly from that of food
restriction, and are mainly characterised by adipose atrophy with
marked reduction in adipocyte size and significantly increased
fibrosis in the tissue matrix. In contrast, adipose tissue from pair-
fed animals contain adipocytes that are spherical with only a
moderate decrease in cell size and slightly increased collagen
fibrils. These results illustrate that the striking alterations in
adipose tissue morphology are specific to cancer cachexia in which
catabolism overrides anabolic processes. Ultrastructural analysis
of ‘slimmed’ adipocytes further reveals severe delipidation and
modifications in cell membrane conformation and mitochondrial
structure, consistent with an adipocyte remodelling under the
cachectic state.
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Figure 1 Reduced adiposity in MAC16 tumour-bearing mice. Body
weight change (A), epididymal fat mass (B) and total food intake (C)o f
control (Ctrl), pair-fed (PF) and tumour-bearing mice (MAC16) at day 18
after tumour inoculation. Values are mean 7s.e.m. for eight animals per
group. **Po0.01 vs controls;
wwPo0.01 vs pair-fed.
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sAdipocyte differentiation is orchestrated by a network of
transcription factors, which are activated in a signalling cascade
allowing the expression of adipocyte-specific genes that produce
the differentiated phenotype (Mandrup & Lane, 1997). The present
study has demonstrated for the first time substantial fall in gene
transcription of the key adipogenic factors, C/EBPb, C/EBPa,
PPARg and SREBP-1c, in white fat of cancer cachectic mice. Most
striking of these changes was the major reduction in mRNA levels
of C/EBPa (by 100-fold) and concomitantly its protein expression
being suppressed. The importance of C/EBPa in adipogenesis has
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Figure 2 Morphological characteristics of adipose tissue. (A) Haematoxylin and eosin stained sections of epididymal adipose tissue from control (a), pair-
fed (b) and tumour-bearing (c) mice, by light microscopy. Note many shapeless and shrunken adipocytes are present in the tissue of a tumour-bearing
mouse at day 18 after tumour inoculation. Morphometric analysis of perimeter (B) and sectional area (C) of adipocytes of epididymal adipose tissue from
control, pair-fed and tumour-bearing mice. Values are mean 7s.e.m. for five animals per group. *Po0.05, **Po0.01 vs controls;
wwPo0.01 vs pair-fed. (D)
Light microscopy of Sirius Red stained sections of epididymal adipose tissue from control (a), pair-fed (b) and tumour-bearing (c) mice at day 18 after
tumour inoculation. Marked increase in collagen fibre staining is seen in the interstitial matrix of adipose tissue from tumour-bearing mice.
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Figure 3 Ultrastructure of adipocytes obtained from epididymal adipose tissue. Representative electron micrograph shows adipocytes from a control
mouse containing a large lipid droplet and a thin rim of cytoplasm (A). Adipocytes from a tumour-bearing mouse show marked reductions in size with
dilated interadipocyte space (B). Adipocytes from a tumour-bearing mouse showing thickened peripheral rim of cytoplasm that is mitochondria-rich and
contains multiple small lipid droplets (C). Cell membrane aspect of adipocyte from a control mouse (D). Adipocyte from a tumour-bearing mouse exhibits
irregular cell membrane projections (villous extroflexions) with cytoplasm containing enlarged and electron dense mitochondria (E). Higher magnification of
the same cell shows mitochondria with increased cristae and dense inner matrix (F). L, lipid droplet; Cap, capillary; N, nucleus; m, mitochondrion; v, villous
extroflexions.
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sbeen shown from studies where C/EBPa-deficiency in mice leads to
greatly reduced body fat (Wang et al, 1995), and C/EBPa-deficient
adipocytes accumulate less lipid, cannot induce PPARg expression
and display a complete absence of insulin-stimulated glucose
transport (Wu et al, 1999). Our observations suggest that markedly
decreased expression of adipogenic transcription factors would
disrupt new adipocyte recruitment and maintaining adipocyte
phenotype in cancer cachexia.
The presence of adipogenic defects in adipose tissue in cachexia
is further supported by the dramatic reduction in mRNA levels of
leptin, a mature adipocyte marker. This is consistent with our
previous reports (Bing et al, 2001, 2004) and the studies using
other rodent models of cancer cachexia (Lopez-Soriano et al,
1997b; Machado et al, 2004). We have also observed a decrease in
Glut-4 mRNA in white fat of cachectic mice, which suggests altered
glucose metabolism. Indeed, glucose metabolic rate in white fat has
been shown to be decreased in mice treated with a tumour-derived
lipid-mobilising factor (Russell & Tisdale, 2002). Downregulation
of Glut-4 activity and protein in fat cells has also been reported in
tumour-bearing rats and this might lead to reduced insulin
sensitivity in adipocytes (Yoshikawa et al, 1997). Moreover,
reduced Glut-4 expression could be a downstream effect of
inhibited C/EBPa since the absence of this factor is associated
with abnormal subcellular localisation of Glut-4 (Rosen, 2005).
The present study has shown that SREBP-1c mRNA and protein
were significantly decreased in white fat of cachectic animals.
SREBP-1c is known to promote lipogenesis through transcriptional
regulation of fatty acid biosynthetic enzymes (Horton, 2002).
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Figure 4 Expression levels of genes involved in adipogenesis (A), lipid accumulation (B) and lipid utilisation (C) in white fat. Real-time PCR analysis of
RNA isolated from epididymal adipose tissue of control, pair-fed and tumour-bearing mice was performed. mRNA levels of target genes were normalised to
b-actin. Values are mean 7s.e.m. presented as fold changes relative to controls for eight animals per group. *Po0.05, **Po0.01 vs controls;
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wwPo0.01 vs pair-fed. (D) Western blotting analysis of protein extracts from epididymal adipose tissue. Representative blots for C/EBPa and b-tubulin
proteins (a), and for SREBP-1 and b-tubulin proteins (b).
Suppression of adipogenic factors in cancer cachexia
C Bing et al
1034
British Journal of Cancer (2006) 95(8), 1028–1037 & 2006 Cancer Research UK
T
r
a
n
s
l
a
t
i
o
n
a
l
T
h
e
r
a
p
e
u
t
i
c
sRepression of SREBP-1c and its targets (ACC, FAS, SCD-1 and
GPAT) in the pathway of fatty acid and triglyceride synthesis may
indicate an inhibition of de novo lipogenesis in adipose tissue in
cancer cachexia. Furthermore, reduced lipogenesis would result in
a decreased amount of malonyl CoA, the product of ACC activity
and an inhibitor of mitochondrial b-oxidation, which would be
expected to remove an inhibitory regulator of fatty acid utilisation.
A growing body of evidence suggests a key role for PGC-1a in
the coordination of mitochondrial biogenesis, and its overexpres-
sion stimulates mitochondrial proliferation (Puigserver et al,
1998). We have observed a major induction of PGC-1a mRNA in
adipose tissue of tumour-bearing mice. Normally, PGC-1a is
present in white fat at very low levels, as seen in this study, being
only 5% of its basal levels in BAT. However, it rose considerably
(by 13-fold) in white fat of mice with cancer cachexia. This result
provides evidence that low levels of PGC-1a transcripts in white fat
can be induced in cancer cachexia and its upregulation may
indicate altered mitochondrial activity in fat cells. The present
study has also shown an increase in mRNA levels of UCP-2, which
is implicated in fatty acid utilisation and in reducing the
generation of reactive oxygen species (Thompson & Kim, 2004).
Moreover, we have observed ultrastructural changes of adipocytes
from adipose tissue of cachectic mice. These ‘slimmed’ adipocytes
often contained multiple lipid droplets surrounded by increased
mass of mitochondria which were electron dense. Collectively,
these findings suggest that adipose atrophy could be associated
with alterations in mitochondrial plasticity and activity in cancer
cachexia. Further studies are required to establish functional
changes of mitochondria in adipose tissue wasting.
The potential mediators of lipoatrophy in cachexia are generally
considered to be proinflammatory cytokines and lipid mobilising
factors. TNFa has been shown to affect adipose tissue formation by
inhibiting the differentiation of new adipocytes, causing dediffer-
entiation of mature fat cells and suppressing the expression of
genes encoding key lipogenic enzymes (Zhang et al, 1996). IL-6
alone cannot inhibit preadipocyte differentiation in vitro (Simons
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set al, 2005) while increased mRNA levels of IL-6 and TNFa as well
as increased MAC infiltration in adipose tissue have been reported
in patients with HIV-related lipodystrophy under antiretroviral
therapy (Jan et al, 2004). However, our data do not support a
major role for these cytokines in the mediation of adipose atrophy
in MAC16-induced cachexia. In our study, gene transcription of
TNFa and IL-6 in white fat was not affected with tumour burden,
in agreement with our previous report that their circulating levels
were unchanged in cachectic mice (Bing et al, 2000). Moreover, we
have illustrated morphologically no apparent monocyte infiltration
in white fat, in parallel to the absence of an increase in mRNA
levles of the MAC markers. Interestingly, our recent work suggests
that a lipid-mobilising factor, ZAG overproduced by certain
malignant tumours including the MAC16 (Todorov et al, 1998;
Hale et al, 2001) and also expressed by white fat (Bing et al, 2004),
might be responsible. In the present study, we have shown a
marked increase in ZAG mRNA in white fat of cachectic mice,
consistent with the previous report which has also shown an
upregulation of its protein content in the tissue (Bing et al, 2004),
suggesting that ZAG may act locally as well as at a distance to
influence adipocyte metabolism. Further work is needed to
establish whether ZAG has a major role in adipose tissue formation
and function.
The work presented in this study demonstrates pronounced
morphologic and molecular alterations of white fat in tumour-
bearing animals, which indicates a strong cachectic effect of the
MAC16 tumour on adipose tissue preventing lipid storage. The
downregulation of the key adipogenic factors (C/EBPb, C/EBPa,
PPARg and SREBP-1c) together with the repression of lipogenic
factors (ACC, FAS, SCD-1, GPAT and Glut-4) suggests that
impairment in the formation and lipid storing capacity of adipose
tissue occurs in cancer cachexia.
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